Literature DB >> 12792174

Determination of cerebrovascular reactivity by means of FMRI signal changes in cerebral microangiopathy: a correlation with morphological abnormalities.

Margret Hund-Georgiadis1, Stefan Zysset, Shinji Naganawa, David G Norris, D Yves Von Cramon.   

Abstract

BACKGROUND AND
PURPOSE: A reduced cerebrovascular reactivity (CR) is a risk factor of cerebrovascular disease. In this study, we implemented a protocol to assess CR by means of functional MRI (fMRI) using hyperventilation. SUBJECTS AND METHODS: In 5 patients with cerebral microangiopathy (CM/lacunar infarction and white matter degeneration), 6 healthy elderly subjects (age-matched control), and 6 young healthy subjects, the CR in response to hyperventilation was evaluated by fMRI using gradient echo-planar Imaging. The percentage signal change normalized by end-tidal CO(2) value was measured in various brain regions.
RESULTS: All subjects performed hyperventilation well without adverse reaction and significant gross motion. Patients with CM showed significant qualitative and quantitative differences (p < 0.05) as compared to controls. The volume of gray matter showing significant CR was significantly reduced in patients: by 40% in comparison to the age-matched elderly control group and by 60% when compared with the young controls. The CR impairment was most pronounced in the frontal cortices with a drastically reduced magnitude of the magnetic resonance (MR) signal change in the patients (-0.62 +/- 0.2% in patients versus -2.0 +/- 0.36% in age-matched controls, p < 0.0001). A strong relation was evident between the fMRI-based CR reduction in patients with CM and the individual severity of structural MR abnormalities (p = 0.002).
CONCLUSION: This study demonstrates that fMRI-based signal changes in response to hyperventilation reliably reflect cerebral vasoreactivity. The protocol is feasible in healthy young and elderly controls and patients with CM. Quantitative and qualitative assessment of the signal decrease in the T(2)-weighted MR sequence and coregistration with individual anatomical data allow the generation of an individual cerebral vasoreactivity map. Future research will address the effect of CR reduction on neuropsychological parameters in patients with CM. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12792174     DOI: 10.1159/000070596

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  7 in total

1.  Whole-brain vascular reactivity measured by fMRI using hyperventilation and breath-holding tasks: efficacy of 3D prospective acquisition correction (3D-PACE) for head motion.

Authors:  Shinji Naganawa; Tokiko Koshikawa; Hiroshi Fukatsu; Takeo Ishigaki; Katsuya Maruyama; Osamu Takizawa
Journal:  Eur Radiol       Date:  2004-05-01       Impact factor: 5.315

2.  Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease.

Authors:  Uma S Yezhuvath; Jinsoo Uh; Yamei Cheng; Kristin Martin-Cook; Myron Weiner; Ramon Diaz-Arrastia; Matthias van Osch; Hanzhang Lu
Journal:  Neurobiol Aging       Date:  2010-03-31       Impact factor: 4.673

Review 3.  Neuroimaging of vascular reserve in patients with cerebrovascular diseases.

Authors:  Meher R Juttukonda; Manus J Donahue
Journal:  Neuroimage       Date:  2017-10-12       Impact factor: 6.556

Review 4.  Magnetic resonance imaging for assessment of cerebrovascular reactivity in cerebral small vessel disease: A systematic review.

Authors:  Gordon W Blair; Fergus N Doubal; Michael J Thrippleton; Ian Marshall; Joanna M Wardlaw
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-16       Impact factor: 6.200

5.  Visualization of altered neurovascular coupling in chronic stroke patients using multimodal functional MRI.

Authors:  Jakob U Blicher; Charlotte J Stagg; Jacinta O'Shea; Leif Østergaard; Bradley J MacIntosh; Heidi Johansen-Berg; Peter Jezzard; Manus J Donahue
Journal:  J Cereb Blood Flow Metab       Date:  2012-07-25       Impact factor: 6.200

6.  A Comparison of CVR Magnitude and Delay Assessed at 1.5 and 3T in Patients With Cerebral Small Vessel Disease.

Authors:  Michael S Stringer; Gordon W Blair; Yulu Shi; Iona Hamilton; David A Dickie; Fergus N Doubal; Ian M Marshall; Michael J Thrippleton; Joanna M Wardlaw
Journal:  Front Physiol       Date:  2021-06-02       Impact factor: 4.755

7.  Strategies for molecular imaging dementia and neurodegenerative diseases.

Authors:  Bernhard J Schaller
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.